Seizing Global Opportunities in Shanghai: Shaoxing Hantai Pharma Celebrates Success at CPhI China 2026
Release time:
2026-06-30
From June 16 to 18, CPhI China 2026 successfully concluded in Shanghai. Marking its 15th appearance at this prestigious event, Shaoxing Hantai Pharma—a company with 16 years of deep-rooted expertise in the pharmaceutical and chemical sectors—showcased its comprehensive portfolio of pharmaceutical ingredients, intermediates, and fine chemicals. During the three-day exhibition, the company engaged in in-depth trade discussions with both new and long-standing clients from Europe, the Americas, Southeast Asia, and the Middle East. Leveraging its resilient supply chain and professional foreign trade services, Hantai Pharma secured multiple letters of intent, effectively expanding its global partnership network.
As a premier global event for the pharmaceutical industry, CPhI China connects upstream and downstream buyers, manufacturers, and professionals worldwide. This year's exhibition focused on critical industry themes, including API and ingredient trading, international collaboration, and compliant supply chains. The bustling exhibition floor witnessed an influx of domestic and international industry peers, unleashing robust market demand and strong collaborative synergy.
Throughout the event, Hantai Pharma’s business team remained fully engaged, providing meticulous and dedicated service to international visitors. The team held extensive discussions on key topics, including product sourcing channels, supply stability, export qualifications, and customized procurement for various pharmaceutical ingredients and fine chemicals. Capitalizing on years of industry resource accumulation and a mature supply chain network, Hantai Pharma delivered cost-effective sourcing solutions to clients while addressing critical inquiries regarding export registration, lead times, and quality control. These fruitful interactions led to several preliminary cooperation agreements on-site.
Having dedicated years to the pharmaceutical and chemical trade, Shaoxing Hantai Pharma has built a solid industry reputation through reliable product sourcing, customer-centric services, and comprehensive import-export support. This exhibition not only allowed the company to gain precise insights into current global market trends but also further broadened its international business horizons.
The conclusion of the exhibition marks the beginning of new partnerships. Moving forward, Hantai Pharma will actively follow up on the leads and intents generated during the event to solidify new relationships. Looking ahead, the company remains committed to integrating premium supply chain resources and optimizing its import-export framework. By providing professional and efficient trade services, Hantai Pharma aims to join hands with global partners to unlock new horizons in the international pharmaceutical and chemical markets.
Key words:
More information
Hantai Pharma (Group) was established in April 2010 and is headquartered in Xinchang County, Shaoxing City, Zhejiang Province. The company's industry involves pharmaceutical raw materials, chemical intermediates, pharmaceutical excipients